M&A Deal Summary |
|
|---|---|
| Date | 2020-09-03 |
| Target | New American Therapeutics - ZONTIVITY |
| Sector | Life Science |
| Buyer(s) | Legacy-Xspire |
| Sellers(s) | New American Therapeutics |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2019 |
| Sector | Life Science |
Legacy-Xspire market and distribute niche branded and generic prescription products to physicians, pharmacies, wholesale distributors, and specialty pharmaceutical distributors across the United States. Legacy-Xspire’s product portfolio consists primarily of therapies for pain management and steroid-responsive disease states. Legacy-Xspire is based in Ridgeland, Mississippi.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science M&A | 4 of 4 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 4 of 4 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-18 |
Xspire Pharma
Madison, Mississippi, United States Xspire Pharma LLC is a privately held, specialty pharmaceutical company prides itself on patient-centered, niche branded and generic pharmaceuticals that fill a void in the prescription market space. Xspire Pharma was established in 2011 and is based in Madison, Mississippi. |
Buy | - |
| Category | Company |
|---|---|
| Sector | Life Science |
New American Therapeutics, Inc. is a privately held, specialty pharmaceutical company that acquires, markets, and develops products in select therapeutic areas. New American Therapeutics is based in Parsippany, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
